Marker | Group | Pre-immunized (%) | 1st immunized (%) | 2nd immunized (%) |
---|---|---|---|---|
CD4+ | PBS | 23.74 ± 3.21a | 24.18 ± 1.94a | 24.68 ± 3.58a |
pVAX1.0 control | 24.28 ± 3.67a | 25.26 ± 3.55a | 25.12 ± 2.84a | |
pET-32a(+) control | 24.04 ± 3.39a | 23.32 ± 2.88a | 24.50 ± 2.13a | |
rEmSAG | 23.12 ± 3.4a | 28.14 ± 4.67a | 35.70 ± 2.94b | |
pVAX-EmSAG | 24.96 ± 1.66a | 35.24 ± 3.51b | 40.92 ± 7.66b | |
CD8+ | PBS | 34.74 ± 3.13a | 34.18 ± 3.94a | 35.16 ± 1.94a |
pVAX1.0 control | 34.64 ± 1.35a | 35.26 ± 3.65a | 35.08 ± 2.89a | |
pET-32a(+) control | 35.32 ± 2.57a | 34.20 ± 5.37a | 34.84 ± 3.72a | |
rEmSAG | 34.8 ± 6.19a | 45.44 ± 3.83b | 57.02 ± 1.85b | |
pVAX-EmSAG | 34.28 ± 5.61a | 49.04 ± 2.76b | 64.28 ± 3.65c |